These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. Hong CH; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Hong HP; Shin JH J Gastroenterol Hepatol; 2009 Mar; 24(3):372-8. PubMed ID: 19032446 [TBL] [Abstract][Full Text] [Related]
85. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. Siramolpiwat S World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012 [TBL] [Abstract][Full Text] [Related]
86. The current knowledge about the therapeutic use of endoscopic sclerotherapy and endoscopic tissue adhesives in variceal bleeding. Al-Khazraji A; Curry MP Expert Rev Gastroenterol Hepatol; 2019 Sep; 13(9):893-897. PubMed ID: 31389265 [No Abstract] [Full Text] [Related]
91. Endoscopic treatment of oesophageal varices. Krige JE; Bornman PC S Afr J Surg; 2000 Dec; 38(4):82-8. PubMed ID: 11424860 [TBL] [Abstract][Full Text] [Related]
92. Balloon-occluded retrograde transvenous obliteration using a dual venous access and sheath system. Shukla PA; Kumar A; Kolber MK; Markowitz T; Patel RI Diagn Interv Imaging; 2016 Apr; 97(4):495-8. PubMed ID: 26776228 [No Abstract] [Full Text] [Related]
93. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241 [TBL] [Abstract][Full Text] [Related]
94. The use of transjugular intrahepatic portosystemic stent shunt (TIPS) in the management of portal hypertensive bleeding. Lo GH J Chin Med Assoc; 2014 Aug; 77(8):395-402. PubMed ID: 25028297 [TBL] [Abstract][Full Text] [Related]
95. Variceal bleeding and portal hypertension: much to learn, much to explore. Bhasin DK; Malhi NJ Endoscopy; 2002 Feb; 34(2):119-28. PubMed ID: 11822007 [TBL] [Abstract][Full Text] [Related]
96. Balloon-occluded retrograde transvenous obliteration for treatment of gastric varices. Waguri N; Osaki A; Watanabe Y World J Hepatol; 2021 Jun; 13(6):650-661. PubMed ID: 34239700 [TBL] [Abstract][Full Text] [Related]
97. Nonendoscopic management strategies for acute esophagogastric variceal bleeding. Satapathy SK; Sanyal AJ Gastroenterol Clin North Am; 2014 Dec; 43(4):819-33. PubMed ID: 25440928 [TBL] [Abstract][Full Text] [Related]
98. Comparison of Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Using Ethanolamine Oleate (EO), BRTO Using Sodium Tetradecyl Sulfate (STS) Foam and Vascular Plug-Assisted Retrograde Transvenous Obliteration (PARTO). Kim YH; Kim YH; Kim CS; Kang UR; Kim SH; Kim JH Cardiovasc Intervent Radiol; 2016 Jun; 39(6):840-6. PubMed ID: 26757912 [TBL] [Abstract][Full Text] [Related]
99. Balloon-occluded Retrograde Transvenous Obliteration of Portovenous Shunts During Endoscopic Therapy for the Treatment of Gastric Varices. Ma LL; Luo TC; Tseng YJ; Huang XQ; Luo JJ; Zhang W; Li B; Chen SY Surg Laparosc Endosc Percutan Tech; 2018 Dec; 28(6):e113-e116. PubMed ID: 30222693 [TBL] [Abstract][Full Text] [Related]
100. Changes in portal systemic pressure gradient after balloon-occluded retrograde transvenous obliteration of gastric varices and aggravation of esophageal varices. Tanihata H; Minamiguchi H; Sato M; Kawai N; Sonomura T; Takasaka I; Nakai M; Sahara S; Nakata K; Shirai S Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1209-16. PubMed ID: 19688368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]